At a glance
- Originator Burroughs Wellcome
- Class Antivirals; Nucleosides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued HIV-1 infections
Most Recent Events
- 23 May 1995 New profile
- 22 May 1995 Discontinued-Preclinical for HIV-1 infections in USA (Unknown route)